证券记录 · 已归档季度
RXST
RxSight, Inc. · Healthcare · Medical - Devices
12被追踪持有人
—Δ持有人
2.73M持有股份
$164.29M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -7 | 30.76M | $148.37M | +3 | −9 |
| Q1 2026 | 78 | +10 | 29.02M | $178.70M | +11 | −1 |
| Q4 2025 | 68 | 0 | 28.07M | $292.47M | +1 | −1 |
| Q3 2025 | 17 | 0 | 14.88M | $133.76M | +1 | −1 |
| Q2 2025 | 14 | 0 | 12.67M | $164.75M | +1 | −1 |
| Q1 2025 | 11 | -1 | 4.08M | $103.15M | — | −1 |
| Q4 2024 | 12 | 0 | 5.10M | $175.38M | — | — |
| Q3 2024 | 11 | -1 | 3.15M | $155.64M | — | −1 |
| Q2 2024 | 12 | — | 2.73M | $164.29M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 694.34K | — | $41.79M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 694.34K | — | $41.79M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 358.21K | — | $21.55M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 358.21K | — | $21.55M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 358.21K | — | $21.55M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 358.21K | — | $21.55M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 341.92K | — | $20.57M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 324.29K | — | $19.51M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 324.29K | — | $19.51M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 274.84K | — | $16.54M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 230.10K | — | $13.85M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 188.59K | — | $11.35M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 127.49K | — | $7.67M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 127.49K | — | $7.67M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 62.94K | — | $3.79M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 58.63K | — | $3.53M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 58.63K | — | $3.53M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 58.63K | — | $3.53M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 37.21K | — | $2.24M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 37.21K | — | $2.24M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Arrowstreet Capital ✦ | 31.71K | — | $1.91M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 162 持有人, 37.72M 股份, $223.80M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据